Apple and Masimo’s legal battle over the Apple Watch’s Blood Oxygen sensing feature continues this week as both firms meet in ...

Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

Masimo delivered Q3 results that mostly aligned with guidance, yet it faces challenges in its non-healthcare segment.

We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...

The healthcare sector depends on medical technology advancements, particularly devices used in disease prevention, diagnosis, ...

In the latest lawsuit, Apple was awarded $250 in damages – the statutory minimum, which was what the company sought in its ...

Apple wins $250 from Masimo in its smartwatch patent infringement case, but the victory doesn’t change much in its larger ...

Masimo (NASDAQ: MASI) today announced that Vanderbilt University Medical Center (VUMC), a renowned healthcare facility in ...

Apple has sought an injunction against health tech maker Masimo’s own smart watches, but it also netted the bare minimum for ...

The jury agreed with Apple that Masimo’s W1 and Freedom watches and chargers willfully violated Apple’s patent rights.

A Delaware jury has ruled in favor of Apple in a patent infringement case against Masimo, awarding Cupertino a symbolic $250 ...

This is the latest development in the long legal battle between Masimo, a medical tech firm, and Apple in which the former alleges the latter unlawfully incorporated its pulse oximetry tech into the ...